Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit.

Intubation Clinical Trial

— IMPROVE  

Official title:

Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04148443
• Other study ID #: CHRO-2019-11
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 2023
• Est. completion date: December 2024

Study information

• Verified date: July 2023
• Source: Centre Hospitalier Régional d'Orléans
• Contact: Aurélie DESPUJOLS
• Phone: 0033238744071
• Email: aurelie.despujols[@]chr-orleans.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Preoxygenation is recommended before performing tracheal intubation. In intensive care units (ICU) patients, there is no specific recommendation regarding the duration of preoxygenation, which usually is applied for 3 to 5 minutes. Monitoring the effectiveness of preoxygenation with end-tidal oxygen concentration (EtO2) is strongly recommended in the operating room but it is never used in ICUs. The first aim of this pilot study is to assess the effect of the preoxygenation duration on EtO2, and secondarily, as an exploratory objective, to determine whether targeting a given value of EtO2 during preoxygenation might insure a safer intubation than when targeting pulse oximetry (SpO2).

Description:

This is a multicenter randomized controlled pilot study. 110 patients who require intubation in the ICU will be randomly assigned, with a 1:1 ratio, to 3 or 5 minutes of preoxygenation duration. EtO2 will be continuously measured but hidden to the clinician. The primary outcome measure will be the obtention of an optimal preoxygenation defined by an EtO2 >90%. Secondary outcomes include the occurrence of hypoxia and complications during the procedure. A pulse oximetry (SpO2) greater than or equal to 96% (SpO2 ≥ 96%) at the end of preoxygenation will be the target in each group. If at the end of the preoxygenation, SpO2 is still lower than 96%, clinician will be allowed to extend the duration of preoxygenation (up to 5 minutes in the 3 minutes period of preoxygenation group and up to 8 minutes in the 5 minutes period of preoxygenation group). End-tidal oxygen concentration (EtO2) will be measured during preoxygenation and will be hidden to the clinician in order to not influence the duration of preoxygenation.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 110
• Est. completion date: December 2024
• Est. primary completion date: December 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients older than 18 years
• Requiring intubation in ICU
• Free express oral and informed consent of the patient or a proxy in case of impossibility for the patient to consent; emergency inclusion possible when legal representatives and patient's family are not present

Exclusion Criteria:

• Intubation for cardiac arrest
• End-tidal oxygen concentration monitoring not available
• Preoxygenation with high-flow nasal oxygenation
• Previous participation to the study
• Patient known, at time of inclusion, as being under guardianship, tutorship or curator
• Pregnancy or breastfeeding
• Lack of social security number

Related Conditions & MeSH terms

• Hypoxia
• Intensive Care Unit
• Intubation
• Preoxygenation

Intervention

Other:
• Preoxygenation
participants will receive 3 minutes of preoxygenation before intubation
• Preoxygenation (longer)
participants will receive 5 minutes of preoxygenation before intubation

Locations

Country	Name	City	State
France	CH de DAX	Dax
France	CHR d'Orléans	Orléans
France	CHRU de TOURS	Tours

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Régional d'Orléans

Country where clinical trial is conducted

France, 

References & Publications (3)

Carrillo A, Gonzalez-Diaz G, Ferrer M, Martinez-Quintana ME, Lopez-Martinez A, Llamas N, Alcazar M, Torres A. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med. 2012 Mar;38(3):458-66. doi: 10.1007/s00134-012-2475-6. Epub 2012 Feb 9. — View Citation

Ozsancak Ugurlu A, Sidhom SS, Khodabandeh A, Ieong M, Mohr C, Lin DY, Buchwald I, Bahhady I, Wengryn J, Maheshwari V, Hill NS. Use and outcomes of noninvasive positive pressure ventilation in acute care hospitals in Massachusetts. Chest. 2014 May;145(5):964-971. doi: 10.1378/chest.13-1707. — View Citation

Thille AW, Frat JP, Brun-Buisson C. Trends in use and benefits of non-invasive ventilation as first-line therapy in acute respiratory failure. Intensive Care Med. 2014 Aug;40(8):1179-80. doi: 10.1007/s00134-014-3370-0. Epub 2014 Jun 25. No abstract available. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of patients who reach an EtO2 of 90%	To compare the percentage of patients who reach an EtO2 of 90% or higher (optimal preoxygenation) at the end of the preoxygenation period between patients randomized in the 3-min and those randomized in the 5-min preoxygenation duration group.	3 minutes
Secondary	Expired oxygen fraction (FeO2)	FeO2 will be recorded at the end of the preoxygenation period	end of the preoxygenation period
Secondary	Incidence of hypoxemia	Hypoxemia will be defined by SpO2<90% during the intubation procedure	5 minutes after intubation
Secondary	Incidence of severe hypoxemia	Severe hypoxemia will be defined by SpO2<80% for more than 5 seconds during the intubation procedure from the end of preoxygenation to 5 minutes after invasive mechanical ventilation	End of preoxygenation
Secondary	Incidence of severe complications	Severs complications occuring within 30 minutes following the intubation procedure will be evaluate and compare between the two groups	30 minutes after intubation
Secondary	Lowest Pulsed saturation with Oxygen (SpO2)	The lowest SPO2 obtained within 30 minutes after the end of preoxygenation will be compared between the 2 groups	30 minutes after the end of preoxygenation
Secondary	Expired oxygen fraction (FeO2)	FeO2 during preoxygenation will be recorded every minutes	Through preoxygenantion, i.e., an average of 4 minutes (a minimum of 3 and a maximum of 8 minutes)
Secondary	Partial Pressure of Oxygen (PaO2)	Measurement of PaO2	0 minute
Secondary	Partial Pressure of Oxygen	Measurement of PaO2 at the end of the preoxygenation	at the 4th minute on average (3rd or 5th minute depending on the randomisation group)